Patients with primary nasal lymphoma usually present Primary nasal T or NK cell lymphoma is rarely seen in the Western population but is more common in the with local nasal symptoms and the tumour is often clinically localised. 3, 8 However, the prognosis is generally poor Orientals. Although it often presents with localized disease, the prognosis is generally poor. Long-term as compared with their nodal counterparts. 8 Durable remission is only seen in around 50% of stage I patients remission is seen in only 50% of patients with stage I disease despite aggressive treatment with chemotherapy and the disease is invariably fatal if disseminated. For patients with relapsed disease, the prognosis is also dismal and radiotherapy, and is invariably fatal if disseminated. Conventional chemotherapy for relapsed disease as they almost all die with progressive disease within 1 year from the time of relapse. High-dose chemotherapy and is usually not successful. Since 1992, three patients with relapsed primary nasal T/NK cell lymphoma have autologous stem cell rescue has been shown to be an effective therapy for patients with relapsed aggressive nonreceived high-dose chemotherapy with autologous bone marrow rescue at Queen Mary Hospital, Hong Kong.
Hodgkin's lymphoma. 9 We report our experience of using the approach to manage three patients with relapsed priHigh-dose cyclophosphamide, BCNU and etoposide were used for conditioning. Two of them had a favourmary nasal lymphoma. able response and remained in complete remission at 12 and 44 months post-transplant. The third patient unfortunately had a systemic relapse 6 achieved after three courses of IMVP-16. High-dose tumour unfortunately relapsed 6 months post-transplantation. The patient eventually died of progressive disease. chemotherapy with autologous marrow rescue was given in September 1992, which resulted in complete remission. She tolerated the procedure well except for one episode of neutropenic fever that responded to antibiotic therapy. The patient remains well and free of disease 44 months postDiscussion transplantation.
The second patient was a 34-year-old woman. She Primary nasal T/NK cell lymphoma is often classified as presented with nasal bleeding in 1978 and was diagnosed to an angiocentric lymphoma which is characterised by angiohave a clinically localised primary nasal lymphoma (CD2 + , centric and angio-destructive lymphoid infiltrates admixed CD56 + ). A complete remission was achieved with local with plasma cells, eosinophils and histiocytes. 4 As a result radiotherapy alone. Unfortunately, the tumour recurred of the angio-invasion, tissue ischaemia and necrosis are locally in 1994. She was reinduced with CEOP chemousually prominent. Together with its anatomical location, therapy consisting of cyclophosphamide 750 mg/m 2 IVI adequate biopsy tissue for diagnosis is often difficult to day 1, epirubicin 60 mg/m 2 IVI day 1, vincristine 2 mg IVI obtain. The ischaemic nature of the tumour may also partly day 1 and prednisolone 100 mg/m 2 orally days 1 to 5 and explain its poor response to chemotherapy and radioonly a partial remission was achieved after three courses.
therapy. 8 Local tumour recurrence is common following Residual tumour cells persisted even after a further three treatment. courses of IMVP-16 chemotherapy (schedule identical to It has been demonstrated that high-dose chemotherapy that for the first patient). High-dose chemotherapy with with marrow or stem cell rescue is an effective treatment autologous marrow rescue was given in June 1995, for relapsed non-Hodgkin's lymphoma. 9, 10 Durable longresulting in complete remission. She tolerated the procedure term remission can be achieved in a significant proportion well. The patient remains well and free of disease 12 of these patients and favourable results have been seen in months post-transplantation. a group of patients with chemo-sensitive disease. We are The third patient was a 20-year-old female. She interested in exploring the effectiveness of this treatment presented with nasal bleeding and symptoms of nasal for patients with relapsed primary nasal lymphoma. All obstruction in February 1993. Biopsy of the nasal tumour three patients with primary nasal lymphoma who had highrevealed a primary nasal lymphoma (CD2 + , CD56 + ). Stagdose chemotherapy and autologous bone marrow transplant ing investigations confirmed that she had disease localised in our hospital had either partial or complete remission folto the nasal cavity. A complete remission was achieved lowing salvage chemotherapy before transplant. Durable after six courses of m-BACOD chemotherapy consisting of complete remission was observed in two of them. It appears bleomycin 4 mg/m 2 IVI day 1, doxorubicin 45 mg/m 2 IVI from this initial experience that high-dose chemotherapy day 1, cyclophosphamide 600 mg IVI day 1, vincristine 2 and autologous bone marrow transplantation is an effective mg IVI day 1, dexamethasone 6 mg/m 2 orally days 1 to 5 treatment for relapse primary nasal T/NK cell lymphoma and methotrexate 200 mg/m 2 IVI days 8 and 15 (with folfollowing failure of conventional chemotherapy. inic acid rescue). It was further consolidated by local radiotherapy. Unfortunately, the tumour recurred locally in November 1993. A second complete remission was achieved with three courses of IMVP-16 chemotherapy (schedule
